{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:42:42Z","timestamp":1788414162704,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005014","name":"Northrop Grumman","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.amepre.2019.11.017","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:56:28Z","timestamp":1582167388000},"page":"526-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016\u20132017"],"prefix":"10.1016","volume":"58","author":[{"given":"Ruth N.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina J.","family":"Weidle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth C.","family":"Lovegrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen O.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Goring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana K.","family":"McAninch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-2623","authenticated-orcid":false,"given":"Daniel S.","family":"Budnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2019.11.017_bib0001","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning.www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or. Updated September 20, 2017. Accessed June 18, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0002","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2018"},{"issue":"1","key":"10.1016\/j.amepre.2019.11.017_bib0003","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.amepre.2019.11.017_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)00468-5","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.amepre.2019.11.017_bib0006","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and non-benzodiazepine hypnotics from 1999 to 2014: results from the National Health and Nutrition Examination Survey","volume":"69","author":"Kaufmann","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0007","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2019.11.017_bib0008","unstructured":"Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013."},{"key":"10.1016\/j.amepre.2019.11.017_bib0009","unstructured":"EH Crane. Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-related Emergency Department Visits. CBHSQ Rep. Rockville, MD: Center for Behavioral Health Statisticsand Quality, Substance Abuse and Mental Health Services Administration, 2013. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DAWN127\/DAWN127\/sr127-DAWN-highlights.htm. Published February 22, 2013. Accessed January 24, 2020."},{"issue":"23","key":"10.1016\/j.amepre.2019.11.017_bib0010","first-page":"705","article-title":"Emergency department visits involving nonmedical use of selected prescriptions drugs \u2013 United States, 2004\u20132008","volume":"59","author":"Cai","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.amepre.2019.11.017_bib0011","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.amepre.2018.12.009","article-title":"U.S. emergency department visits resulting from nonmedical use of pharmaceuticals, 2016","volume":"56","author":"Geller","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2019.11.017_bib0012","unstructured":"Schroeder T, Ault K, Division of Hazard and Injury Data Systems, U.S. Consumer Product Safety Commission. The NEISS sample \u2013 design and implementation 1997 to present. www.cpsc.gov\/s3fs-public\/pdfs\/blk_media_2001d011-6b6.pdf. Published 2001. Accessed December 10, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0013","unstructured":"CDC. Distinguishing public health research and public health nonresearch. www.cdc.gov\/od\/science\/integrity\/docs\/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. Published 2010. Accessed May 5, 2019."},{"issue":"10 suppl 2","key":"10.1016\/j.amepre.2019.11.017_bib0014","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/MLR.0b013e318041f737","article-title":"Evaluation and overview of the National Electronic Injury Surveillance System\u2013Cooperative Adverse Drug Event Surveillance Project (NEISS\u2013CADES)","volume":"45","author":"Jhung","year":"2007","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.amepre.2019.11.017_bib0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2105\/AJPH.2019.305007","article-title":"U.S. emergency department visits for acute harms from prescription opioid use, 2016\u20132017","volume":"109","author":"Lovegrove","year":"2019","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.amepre.2019.11.017_bib0016","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ADM.0000000000000170","article-title":"Things that work, things that don't work, and things that matter \u2013 including words","volume":"9","author":"Saitz","year":"2015","journal-title":"J Addict Med"},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0017","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2012.301191","article-title":"Language and addiction: choosing words wisely","volume":"103","author":"Wakeman","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2019.11.017_bib0018","unstructured":"CDC. Bridged-race population estimates: 1990\u20132016. https:\/\/wonder.cdc.gov\/bridged-race-population.html. Updated November 19, 2019. Accessed January 24, 2020."},{"issue":"1","key":"10.1016\/j.amepre.2019.11.017_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J Pharm Pract"},{"issue":"2","key":"10.1016\/j.amepre.2019.11.017_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002\u20132014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2019.11.017_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev Med Rep"},{"issue":"6","key":"10.1016\/j.amepre.2019.11.017_bib0022","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2018.0544","article-title":"Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States","volume":"75","author":"Ladapo","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.amepre.2019.11.017_bib0023","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.amepre.2019.11.017_bib0025","first-page":"13","article-title":"Judicious prescribing of benzodiazepines","volume":"35","year":"2016","journal-title":"City Health Inf"},{"key":"10.1016\/j.amepre.2019.11.017_bib0026","unstructured":"Levine RL, Real LA, Julius R, et al. Prescribing guidelines for Pennsylvania. The Commonwealth of Pennsylvania.www.overdosefreepa.pitt.edu\/wp-content\/uploads\/2016\/10\/Benzo-for-anxiety-and-insomnia-FINAL-002.pdf. Updated October 18, 2016. Accessed September 5, 2019."},{"issue":"6","key":"10.1016\/j.amepre.2019.11.017_bib0027","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/ADM.0000000000000354","article-title":"Concurrent use of opioids and benzodiazepines: evaluation of prescription drug monitoring by a United States laboratory","volume":"11","author":"McClure","year":"2017","journal-title":"J Addict Med"},{"key":"10.1016\/j.amepre.2019.11.017_bib0028","unstructured":"CDC. Planning and implementing screening and brief intervention forrisky alcohol use: a step-by-step guide for primary care practices. Atlanta, GA: CDC, National Center on Birth Defects and Developmental Disabilities. www.cdc.gov\/ncbddd\/fasd\/documents\/AlcoholSBIImplementationGuide-P.pdf. Published 2014. Accessed June 24, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2017.05.016","article-title":"High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City","volume":"46","author":"Mateu-Gelabert","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.amepre.2019.11.017_bib0030","unstructured":"DM Bush. Emergency Department Visits Involving Nonmedical Use of Anti-anxiety Medication Alprazolam. CBHSQ Report. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health ServicesAdministration, 2014. https:\/\/atforum.com\/documents\/TEDS028BenzoAdmissions.pdf. Published June 2, 2011. Accessed January 24, 2020."},{"key":"10.1016\/j.amepre.2019.11.017_bib0031","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The TEDS report: substance abuse treatment admissions for abuse of benzodiazepines. Rockville, MD. http:\/\/atforum.com\/documents\/TEDS028BenzoAdmissions.pdf. Published 2011. Accessed December 10, 2019."},{"issue":"1\u20132","key":"10.1016\/j.amepre.2019.11.017_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"10.1016\/j.amepre.2019.11.017_bib0033","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMp1801417","article-title":"Suicide: a silent contributor to opioid-overdose deaths","volume":"378","author":"Oquendo","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2019.11.017_bib0034","unstructured":"U.S. Preventive Services Task Force. Final recommendation statement: suicide risk in adolescents, adults and older adults: screening.www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/suicide-risk-in-adolescents-adults-and-older-adults-screening\/. Published 2019. Accessed July 14, 2019."},{"issue":"1","key":"10.1016\/j.amepre.2019.11.017_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1017\/S2045796016000871","article-title":"Emergency department visits for attempted suicide and self harm in the USA: 2006\u20132013","volume":"27","author":"Canner","year":"2018","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.amepre.2019.11.017_bib0036","unstructured":"National Institute on Drug Abuse. Principles of substance abuse prevention for early childhood: a research-based guide.www.drugabuse.gov\/publications\/principles-substance-abuse-prevention-early-childhood\/table-contents. Published 2016. Accessed May 5, 2019."},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0037","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2105\/AJPH.2012.301209","article-title":"Longitudinal effects of universal preventive intervention on prescription drug misuse: three randomized controlled trials with late adolescents and young adults","volume":"103","author":"Spoth","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2019.11.017_bib0038","series-title":"Preventing Suicide: A Technical Package of Policy, Programs, and Practices","author":"Stone","year":"2017"},{"key":"10.1016\/j.amepre.2019.11.017_bib0039","unstructured":"CDC. PROTECT Initiative: advancing children's medication safety. www.cdc.gov\/medicationsafety\/protect\/protect_initiative.html. Updated October 30, 2017. Accessed May 5, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0040","unstructured":"UpAndAway.org. Put your medicines up and away and out of sight. www.upandaway.org\/. Accessed November 4, 2019."},{"issue":"7","key":"10.1016\/j.amepre.2019.11.017_bib0041","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1197\/j.aem.2007.04.005","article-title":"Identifying injection drug users at risk of nonfatal overdose","volume":"14","author":"Coffin","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"6","key":"10.1016\/j.amepre.2019.11.017_bib0042","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jamapsychiatry.2014.3188","article-title":"Risk of suicide following deliberate self-poisoning","volume":"72","author":"Finkelstein","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.amepre.2019.11.017_bib0043","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jad.2018.10.372","article-title":"Method of self-harm and risk ofself-harm repetition: findings from a national self-harm registry","volume":"246","author":"Cully","year":"2019","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.amepre.2019.11.017_bib0044","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1197\/j.aem.2005.11.072","article-title":"Subsequent suicide mortality among emergency department patients seen for suicidal behavior","volume":"13","author":"Crandall","year":"2006","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.amepre.2019.11.017_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amepre.2019.11.017_bib0046","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.2011.10101476","article-title":"Risk of death from accidental overdose associated with psychiatric and substance use disorders","volume":"169","author":"Bohnert","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amepre.2019.11.017_bib0047","unstructured":"Substance Abuse and Mental Health Services Administration. Drug abuse warning network, 2010. Methodology report.www.samhsa.gov\/data\/report\/drug-abuse-warning-network-2010-methodology-report%C2%A0. Published 2014. Accessed October 30, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0048","unstructured":"CDC. Opioid overdose \u2013 commonly used terms. www.cdc.gov\/drugoverdose\/opioids\/terms.html. Updated February 12, 2019. Accessed October 30, 2019."},{"key":"10.1016\/j.amepre.2019.11.017_bib0049","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Drug abuse and dependence section of labeling for human prescription drug and biological products \u2013 content and format guidance for industry.www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-abuse-and-dependence-section-labeling-human-prescription-drug-and-biological-products-content. Published 2019. Accessed November 5, 2019."}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379720300076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379720300076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:53:55Z","timestamp":1760082835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379720300076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0749379720300076"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2019.11.017","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016\u20132017","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2019.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}